Laboratory Retained Earnings from 2010 to 2024

LH Stock

USD 241.16 0.99 0.41%

Laboratory's Retained Earnings are increasing with slightly volatile movements from year to year. Retained Earnings are estimated to finish at about 8.3 B this year. Retained Earnings is the cumulative amount of net income that Laboratory of retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

1989-03-31

Previous Quarter

8.2 B

Current Value

8.3 B

Quarterly Volatility

3.3 B

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.

Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Laboratory of over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Laboratory's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 7.89 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Laboratory Retained Earnings Regression Statistics

	Arithmetic Mean	6,082,020,667
	Geometric Mean	4,553,684,209
	Coefficient Of Variation	50.00
	Mean Deviation	2,554,992,622
	Median	6,224,000,000
	Standard Deviation	3,041,028,666
	Sample Variance	9247855.3T
	Range	10.5B
	R-Value	0.91
	Mean Square Error	1648101.3T
	R-Squared	0.83
	Slope	621,187,393
	Total Sum of Squares	129469974.9T

Laboratory Retained Earnings History

	2024	8.3 B
	2023	7.9 B
	2022	10.6 B
	2021	10.5 B
	2020	9.4 B
	2019	7.9 B
	2018	7.1 B

Other Fundumenentals of Laboratory

Retained Earnings Total Equity

Laboratory Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.93	0.95	0.92	0.95	0.98	0.94	0.9	0.06	0.57	0.84	0.9	0.94	-0.73	0.31	0.8	-0.34	0.91	-0.44	0.54	-0.48	0.1	0.45	0.53	0.49	-0.68
Total Stockholder Equity	0.98		0.84	0.98	0.92	0.96	0.92	0.97	0.83	0.09	0.48	0.73	0.92	0.89	-0.66	0.37	0.85	-0.16	0.82	-0.57	0.44	-0.5	0.09	0.53	0.63	0.59	-0.78
Net Debt	0.93	0.84		0.78	0.89	0.79	0.97	0.75	0.92	0.04	0.61	0.91	0.8	0.91	-0.74	0.11	0.65	-0.63	0.97	-0.22	0.67	-0.48	0.19	0.13	0.27	0.17	-0.49
Retained Earnings	0.95	0.98	0.78		0.89	0.94	0.87	0.96	0.77	0.12	0.54	0.66	0.89	0.84	-0.7	0.36	0.81	-0.05	0.74	-0.57	0.3	-0.4	0.05	0.54	0.66	0.61	-0.8
Accounts Payable	0.92	0.92	0.89	0.89		0.83	0.89	0.85	0.77	0.2	0.55	0.69	0.94	0.8	-0.68	0.17	0.75	-0.25	0.84	-0.46	0.51	-0.67	0.37	0.24	0.45	0.26	-0.76
Net Receivables	0.95	0.96	0.79	0.94	0.83		0.9	0.97	0.79	0.1	0.49	0.72	0.88	0.85	-0.65	0.5	0.8	-0.14	0.8	-0.54	0.42	-0.45	0.07	0.69	0.61	0.64	-0.73
Total Liab	0.98	0.92	0.97	0.87	0.89	0.9		0.87	0.93	0.03	0.63	0.91	0.84	0.95	-0.77	0.24	0.71	-0.5	0.96	-0.3	0.62	-0.45	0.1	0.35	0.41	0.38	-0.56
Total Current Assets	0.94	0.97	0.75	0.96	0.85	0.97	0.87		0.75	0.07	0.46	0.67	0.9	0.82	-0.62	0.47	0.83	-0.03	0.75	-0.58	0.41	-0.47	0.09	0.67	0.7	0.69	-0.78
Intangible Assets	0.9	0.83	0.92	0.77	0.77	0.79	0.93	0.75		-0.08	0.57	0.96	0.67	0.99	-0.71	0.21	0.63	-0.61	0.94	-0.17	0.6	-0.29	-0.12	0.22	0.21	0.38	-0.35
Short Term Debt	0.06	0.09	0.04	0.12	0.2	0.1	0.03	0.07	-0.08		0.27	-0.2	0.24	-0.11	-0.2	0.01	-0.23	0.25	-0.07	-0.1	-0.08	-0.35	0.53	0.06	0.11	-0.15	-0.34
Common Stock	0.57	0.48	0.61	0.54	0.55	0.49	0.63	0.46	0.57	0.27		0.58	0.39	0.54	-0.97	-0.15	0.03	-0.33	0.57	0.29	0.16	-0.07	0.07	0.1	0.12	0.11	-0.2
Long Term Debt	0.84	0.73	0.91	0.66	0.69	0.72	0.91	0.67	0.96	-0.2	0.58		0.57	0.95	-0.7	0.12	0.54	-0.73	0.94	-0.02	0.7	-0.25	-0.17	0.18	0.14	0.31	-0.21
Property Plant Equipment	0.9	0.92	0.8	0.89	0.94	0.88	0.84	0.9	0.67	0.24	0.39	0.57		0.73	-0.54	0.33	0.83	-0.07	0.75	-0.68	0.45	-0.68	0.43	0.43	0.57	0.35	-0.9
Good Will	0.94	0.89	0.91	0.84	0.8	0.85	0.95	0.82	0.99	-0.11	0.54	0.95	0.73		-0.7	0.25	0.72	-0.53	0.93	-0.28	0.6	-0.3	-0.13	0.32	0.33	0.47	-0.45
Treasury Stock	-0.73	-0.66	-0.74	-0.7	-0.68	-0.65	-0.77	-0.62	-0.71	-0.2	-0.97	-0.7	-0.54	-0.7		0.03	-0.24	0.36	-0.69	-0.12	-0.23	0.12	-0.01	-0.21	-0.25	-0.25	0.33
Short Term Investments	0.31	0.37	0.11	0.36	0.17	0.5	0.24	0.47	0.21	0.01	-0.15	0.12	0.33	0.25	0.03		0.46	0.2	0.13	-0.53	0.02	-0.01	-0.03	0.64	0.42	0.56	-0.36
Current Deferred Revenue	0.8	0.85	0.65	0.81	0.75	0.8	0.71	0.83	0.63	-0.23	0.03	0.54	0.83	0.72	-0.24	0.46		-0.06	0.66	-0.78	0.37	-0.47	0.08	0.47	0.58	0.52	-0.75
Net Tangible Assets	-0.34	-0.16	-0.63	-0.05	-0.25	-0.14	-0.5	-0.03	-0.61	0.25	-0.33	-0.73	-0.07	-0.53	0.36	0.2	-0.06		-0.64	-0.41	-0.62	0.05	0.11	0.37	0.36	0.29	-0.33
Long Term Debt Total	0.91	0.82	0.97	0.74	0.84	0.8	0.96	0.75	0.94	-0.07	0.57	0.94	0.75	0.93	-0.69	0.13	0.66	-0.64		-0.19	0.7	-0.5	0.1	0.2	0.17	0.24	-0.42
Capital Surpluse	-0.44	-0.57	-0.22	-0.57	-0.46	-0.54	-0.3	-0.58	-0.17	-0.1	0.29	-0.02	-0.68	-0.28	-0.12	-0.53	-0.78	-0.41	-0.19		-0.03	0.38	-0.23	-0.48	-0.58	-0.41	0.84
Deferred Long Term Liab	0.54	0.44	0.67	0.3	0.51	0.42	0.62	0.41	0.6	-0.08	0.16	0.7	0.45	0.6	-0.23	0.02	0.37	-0.62	0.7	-0.03		-0.55	0.15	0.01	0.0	0.04	-0.11
Long Term Investments	-0.48	-0.5	-0.48	-0.4	-0.67	-0.45	-0.45	-0.47	-0.29	-0.35	-0.07	-0.25	-0.68	-0.3	0.12	-0.01	-0.47	0.05	-0.5	0.38	-0.55		-0.64	-0.15	-0.2	0.01	0.56
Short Long Term Debt	0.1	0.09	0.19	0.05	0.37	0.07	0.1	0.09	-0.12	0.53	0.07	-0.17	0.43	-0.13	-0.01	-0.03	0.08	0.11	0.1	-0.23	0.15	-0.64		-0.16	0.01	-0.48	-0.46
Cash And Equivalents	0.45	0.53	0.13	0.54	0.24	0.69	0.35	0.67	0.22	0.06	0.1	0.18	0.43	0.32	-0.21	0.64	0.47	0.37	0.2	-0.48	0.01	-0.15	-0.16		0.71	0.86	-0.48
Net Invested Capital	0.53	0.63	0.27	0.66	0.45	0.61	0.41	0.7	0.21	0.11	0.12	0.14	0.57	0.33	-0.25	0.42	0.58	0.36	0.17	-0.58	0.0	-0.2	0.01	0.71		0.69	-0.68
Net Working Capital	0.49	0.59	0.17	0.61	0.26	0.64	0.38	0.69	0.38	-0.15	0.11	0.31	0.35	0.47	-0.25	0.56	0.52	0.29	0.24	-0.41	0.04	0.01	-0.48	0.86	0.69		-0.37
Capital Stock	-0.68	-0.78	-0.49	-0.8	-0.76	-0.73	-0.56	-0.78	-0.35	-0.34	-0.2	-0.21	-0.9	-0.45	0.33	-0.36	-0.75	-0.33	-0.42	0.84	-0.11	0.56	-0.46	-0.48	-0.68	-0.37

Click cells to compare fundamentals

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Retained Earnings, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Retained Earnings	7.9 B	8.3 B
Retained Earnings Total Equity	12 B	12.6 B

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Laboratory Correlation against competitors.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

5.28

Revenue Per Share

151.028

Quarterly Revenue Growth

0.074

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Retained Earnings from 2010 to 2024

Latest Laboratory's Retained Earnings Growth Pattern

Laboratory Retained Earnings Regression Statistics

Laboratory Retained Earnings History

Other Fundumenentals of Laboratory

Laboratory Retained Earnings component correlations

About Laboratory Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY